These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37243155)

  • 1. A Novel Recognition by the E3 Ubiquitin Ligase of HSV-1 ICP0 Enhances the Degradation of PML Isoform I to Prevent ND10 Reformation in Late Infection.
    Jan Fada B; Guha U; Zheng Y; Reward E; Kaadi E; Dourra A; Gu H
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
    Jan Fada B; Kaadi E; Samrat SK; Zheng Y; Gu H
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1.
    Zheng Y; Samrat SK; Gu H
    J Virol; 2016 Dec; 90(23):10875-10885. PubMed ID: 27681131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
    Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.
    Cuchet-Lourenço D; Vanni E; Glass M; Orr A; Everett RD
    J Virol; 2012 Oct; 86(20):11209-22. PubMed ID: 22875967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
    Perusina Lanfranca M; Mostafa HH; Davido DJ
    J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
    Zheng Y; Gu H
    J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.
    Everett RD; Boutell C; Pheasant K; Cuchet-Lourenço D; Orr A
    J Virol; 2014 Mar; 88(5):2763-74. PubMed ID: 24352468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
    Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.
    Cuchet D; Sykes A; Nicolas A; Orr A; Murray J; Sirma H; Heeren J; Bartelt A; Everett RD
    J Cell Sci; 2011 Jan; 124(Pt 2):280-91. PubMed ID: 21172801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.
    Lopez P; Jacob RJ; Roizman B
    J Virol; 2002 Sep; 76(18):9355-67. PubMed ID: 12186918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention.
    Gu H; Zheng Y; Roizman B
    J Virol; 2013 Sep; 87(18):10244-54. PubMed ID: 23864622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
    Boutell C; Orr A; Everett RD
    J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
    Negorev DG; Vladimirova OV; Maul GG
    J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.
    Boutell C; Cuchet-Lourenço D; Vanni E; Orr A; Glass M; McFarlane S; Everett RD
    PLoS Pathog; 2011 Sep; 7(9):e1002245. PubMed ID: 21949651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.
    Cuchet-Lourenço D; Anderson G; Sloan E; Orr A; Everett RD
    J Virol; 2013 Dec; 87(24):13422-32. PubMed ID: 24089555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
    Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
    J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Elements Regulating the Nuclear-to-Cytoplasmic Translocation of ICP0 in Late Herpes Simplex Virus 1 Infection.
    Samrat SK; Ha BL; Zheng Y; Gu H
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.
    Everett RD; Parada C; Gripon P; Sirma H; Orr A
    J Virol; 2008 Mar; 82(6):2661-72. PubMed ID: 18160441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.